Cargando…

Analysis of influencing factors on the plasma concentration of first-line anti-tuberculosis drugs-a single-center retrospective cohort study

BACKGROUND: The four most commonly used first-line anti-tuberculosis (TB) drugs in clinical practice are isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The plasma concentration of anti-TB drugs is an important factor influencing the effectiveness of TB treatment. Factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Guanren, Chen, Ming, Sun, Lijun, Xi, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096376/ https://www.ncbi.nlm.nih.gov/pubmed/35571444 http://dx.doi.org/10.21037/atm-22-1341

Ejemplares similares

Correlations among the plasma concentrations of first-line anti-tuberculosis drugs and the physiological parameters influencing concentrations
por: Cheng, Lin, et al.
Publicado: (2023)

Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
por: Kumar, Agibothu Kupparam Hemanth, et al.
Publicado: (2017)

Determinants of serum concentration of first-line anti-tuberculosis drugs from China
por: Lei, Qian, et al.
Publicado: (2019)

Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population
por: Wang, Jun, et al.
Publicado: (2020)

The Distribution Pattern of First-Line Anti-Tuberculosis Drug Concentrations between the Blood and the Vertebral Focus of Spinal Tuberculosis Patients
por: Jiang, Guanyin, et al.
Publicado: (2022)

Clinical impact of plasma concentrations of first-line antituberculosis drugs
por: Perumal, R, et al.
Publicado: (2023)

Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis
por: McCallum, Andrew D, et al.
Publicado: (2020)

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates
por: Schönfeld, Nicolas, et al.
Publicado: (2012)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

ADVERSE EVENTS TO FIRST LINE ANTI-TUBERCULOSIS DRUGS IN PATIENTS CO-INFECTED WITH HIV AND TUBERCULOSIS
por: Michael, O.S., et al.
Publicado: (2016)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

Combining bioinformatics and biological detection to identify novel biomarkers for diagnosis and prognosis of pulmonary tuberculosis
por: Zhao, Guanren, et al.
Publicado: (2020)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia
por: Yigzaw, Wubet Birhan, et al.
Publicado: (2021)

The effects of first-line anti-tuberculosis drugs on the actions of vitamin D in human macrophages
por: Chesdachai, Supavit, et al.
Publicado: (2016)

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid
por: Jiang, Yuhan, et al.
Publicado: (2021)

Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection
por: Xing, Yaru, et al.
Publicado: (2021)

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
por: Davies Forsman, Lina, et al.
Publicado: (2018)

First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors
por: Bouazzi, Omaima El, et al.
Publicado: (2016)

High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs()
por: Sim, Da Woon, et al.
Publicado: (2021)

Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy
por: Bisaso, Kuteesa R, et al.
Publicado: (2014)

First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review
por: Pourakbari, Babak, et al.
Publicado: (2016)

Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda
por: Orikiriza, Patrick, et al.
Publicado: (2015)

Erratum to: Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy
por: Bisaso, Kuteesa R, et al.
Publicado: (2015)

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis
por: Idh, Jonna, et al.
Publicado: (2012)

Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study
por: Ketema, Daniel Bekele, et al.
Publicado: (2019)

Interactive effect of oral anti-hyperglycaemic or anti–hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis
por: Trivedi, Priyanka, et al.
Publicado: (2023)

Plasma lipid concentrations and survival in geriatric population: A retrospective cohort study
por: Wang, Mu-Cyun, et al.
Publicado: (2019)

The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020)

Drug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculous drugs: A five years study
por: Menon, Sarala, et al.
Publicado: (2012)

Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System
por: Chung, Soo Jie, et al.
Publicado: (2022)

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
por: Sanchotene, Karine O., et al.
Publicado: (2008)

Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study
por: Zhao, Hong, et al.
Publicado: (2020)

Changes in smoking status, mental state and plasma clozapine concentration: retrospective cohort evaluation
por: Qurashi, Inti, et al.
Publicado: (2019)

Association between Plasma Homocysteine Concentrations and the First Ischemic Stroke in Hypertensive Patients with Obstructive Sleep Apnea: A 7-Year Retrospective Cohort Study from China
por: Li, Nanfang, et al.
Publicado: (2021)

Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
por: Merid, Mehari Woldemariam, et al.
Publicado: (2019)

There is significant relationship between Beijing genotype family strains and resistance to the first-line anti-tuberculosis drugs in the Iranian population
por: Keikha, Masoud
Publicado: (2020)

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
por: Shrestha, Sourya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_upunrmd3jhi49eantktir3ge33